Johnson & Johnson has announced the FDA’s approval of a first-of-its-kind, esketamine nasal spray called Spravato for the ...

By Tarun Sai Lomte Evidence shows weak antiviral activity and no improvement in symptom outcomes. Study: Antiviral efficacy ...

Researchers identified the most effective screening tools and treatment options for children with obsessive compulsive ...

Johnson & Johnson's Spravato nasal spray has been FDA-approved as a stand-alone therapy for adults with treatment-resistant ...